Patent Docs
This blawg "focuses on recent developments in biotechnology and pharmaceutical patent law. This weblog offers updates regarding changes in patent office rules and procedures that affect biotech/pharma patent prosecution, provides summaries of recent court decisions that impact biotech/pharma patent litigation and prosecution, and monitors newly filed biotech/pharma patent litigation."
Author: Donald Zuhn and Kevin Noonan are partners at McDonnell Boehnen Hulbert & Berghoff in Chicago; Chris Singer and Sherri Oslick are associates at the firm. Jason Derry is an in-house patent attorney.
Blawg Related Categories: Intellectual Property Law • Patent Law • Science & Technology Law • Associate • In-house Lawyer • Partner
Recent Posts from Patent Docs
-
PLI CLE on Quanta Computer, Inc. v. LG Electronics, Inc.
Practising Law Institute (PLI) will be offering an audio webcast entitled: "Life After Quanta v. LGE: What Every Patent Lawyer Needs to Know" on July 7, 2008 from 1:00-2:00 PM (EDT). J. Scott Ballenger of…
-
IPO 2008 Annual Meeting
The Intellectual Property Owners Association (IPO) will be holding its 2008 Annual Meeting on September 21-23, 2008 in San Diego. The meeting will have concurrent patent and trademark sessions. Among the presentations being offered in…
-
CPI Issues Report on Biotech/Pharma Lobbying
By Donald Zuhn -- Last week, the mainstream media turned its attention to the lobbying efforts of biotechnology and pharmaceutical companies. The impetus for this increased coverage was a report on lobbying issued by the…
-
Congressmen Criticize U.S. Trade Representative over Special 301 Report
By Kevin E. Noonan -- Four Congressman recently stepped into the crisis in world drug pricing, sending a letter to U.S. Trade Representative Susan Schwab last Thursday. The letter, signed by Congressman Charles Rangel (NY-15th…
-
CBO Releases Report on Senate Follow-on Biologics Bill; BIO Calls for Congress to Pass Biologics Bill in 2008
By Donald Zuhn -- Last week, the Congressional Budget Office (CBO) released a report on the Biologics Price Competition and Innovation Act (S. 1695), which would establish a pathway for the FDA to approve follow-on…
-
Biotech/Pharma Lobbying Scoreboard - Part II
By Donald Zuhn -- For the past few months, Patent Docs has been following and reporting on biotech and pharma lobbying efforts. Our interest in this topic stems from the push by Congress over the…
-
University of Pittsburgh v. Hedrick (C.D. Cal. 2008)
By Kevin E. Noonan -- On June 9, 2008, the University of Pittsburgh obtained a judgment correcting inventorship of U.S. Patent No. 6,777,231 under 35 U.S.C. § 256. The U.S. District Court for the Central…
-
Court Report
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Eli Lilly and Company…
-
BIO Announces Venues and Dates for Upcoming Conventions
On June 20th, the Biotechnology Industry Organization (BIO) concluded its 2008 International Convention. More than 20,000 attendees from over 2,100 biotech companies, organizations, and institutions -- including Patent Docs authors (and MBHB attorneys) Donald Zuhn,…
-
Conference & CLE Calendar
July 1, 2008 - Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections 102 & 103 (Practising Law Institute) - New York, NY July 9, 2008 - Quanta v. LG:…